Ørsted A/S (DNNGY)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	20,021	18,913	23,323	38,111	53,677	85,844
Market Cap Growth	-21.45%	-18.91%	-38.80%	-29.00%	-37.47%	97.54%
Enterprise Value	32,227	28,292	30,121	45,003	57,590	87,535
PE Ratio	122.39	-	-	18.23	34.33	34.57
PS Ratio	1.90	1.92	1.98	2.32	4.52	10.42
PB Ratio	1.43	1.46	2.02	2.78	4.12	5.37
P/OCF Ratio	8.98	7.42	5.51	22.25	28.89	29.97
EV/Sales Ratio	2.87	2.87	2.56	2.74	4.85	10.62
EV/EBITDA Ratio	8.15	8.73	9.35	15.47	23.95	35.14
EV/EBIT Ratio	13.69	14.44	15.80	27.71	44.71	65.48
EV/FCF Ratio	-6.82	-	-	-	-	-
Debt / Equity Ratio	0.95	1.03	1.13	0.75	0.69	0.43
Debt / EBITDA Ratio	3.59	3.97	3.89	3.40	3.57	2.66
Quick Ratio	0.84	0.99	1.06	0.99	0.48	1.25
Current Ratio	1.24	1.48	1.42	1.51	1.01	1.84
Asset Turnover	0.25	0.25	0.27	0.39	0.33	0.26
Return on Equity (ROE)	2.55%	0.02%	-23.29%	16.60%	11.93%	16.64%
Return on Assets (ROA)	3.30%	3.04%	2.70%	2.42%	2.25%	2.61%
Return on Capital (ROIC)	5.19%	4.96%	4.83%	4.55%	3.72%	3.75%
Return on Capital Employed (ROCE)	6.50%	5.80%	5.80%	4.70%	4.60%	5.00%
Earnings Yield	0.82%	-0.15%	-13.04%	5.70%	3.12%	2.99%
Earnings Yield	0.82%	-0.15%	-13.04%	5.70%	3.12%	2.99%
FCF Yield	-23.59%	-17.84%	-6.15%	-7.95%	-6.39%	-1.82%
Dividend Yield	-	-	-	6.52%	4.58%	2.85%
Payout Ratio	37.01%	-	-	38.22%	47.98%	31.40%
Buyback Yield / Dilution	-0.15%	-0.03%	-0.01%	-0.01%	-0.01%	0.03%
Total Shareholder Return	-	-0.03%	-0.01%	6.50%	4.58%	2.88%

Source: S&P Global Market Intelligence. Utility template. Financial Sources.